Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Pyk2 activation is integral to acid stimulation of sodium/hydrogen exchanger 3
Shaoying Li, … , Patricia A. Preisig, Robert J. Alpern
Shaoying Li, … , Patricia A. Preisig, Robert J. Alpern
Published December 15, 2004
Citation Information: J Clin Invest. 2004;114(12):1782-1789. https://doi.org/10.1172/JCI18046.
View: Text | PDF
Article Cell biology

Pyk2 activation is integral to acid stimulation of sodium/hydrogen exchanger 3

  • Text
  • PDF
Abstract

The present study examines the role of Pyk2 in acid regulation of sodium/hydrogen exchanger 3 (NHE3) activity in OKP cells, a kidney proximal tubule epithelial cell line. Incubation of OKP cells in acid media caused a transient increase in Pyk2 phosphorylation that peaked at 30 seconds and increased Pyk2/c-Src binding at 90 seconds. Pyk2 isolated by immunoprecipitation and studied in a cell-free system was activated and phosphorylated at acidic pH. Acid activation of Pyk2 (a) was specific for Pyk2 in that acid did not activate focal adhesion kinase, (b) required calcium, and (c) was associated with increased affinity for ATP. Transfection of OKP cells with dominant-negative pyk2K457A or small interfering pyk2 duplex RNA blocked acid activation of NHE3, while neither had an effect on glucocorticoid activation of NHE3. In addition, pyk2K457A blocked acid activation of c-Src kinase, which is also required for acid regulation of NHE3. The present results demonstrate that Pyk2 is directly activated by acidic pH and that Pyk2 activation is required for acid activation of c-Src kinase and NHE3. Given that partially purified Pyk2 can be activated by acid in a cell-free system, Pyk2 may serve as the pH sensor that initiates the acid-regulated signaling cascade involved in NHE3 regulation.

Authors

Shaoying Li, Soichiro Sato, Xiaojing Yang, Patricia A. Preisig, Robert J. Alpern

×

Figure 9

Options: View larger image (or click on image) Download as PowerPoint
Pyk2 is required for acid activation of c-Src. OKP cells transiently tra...
Pyk2 is required for acid activation of c-Src. OKP cells transiently transfected with wild-type or dominant-negative (DN) pyk2 and wild-type c-Src were grown to confluence, rendered quiescent, and exposed to control (pH 7.4) or acid (pH 6.8) medium for 90 seconds; c-Src was immunoprecipitated as described in Methods. c-Src kinase activity was assayed using acid-denatured enolase as the substrate. (A) Typical autoradiograph (top) and Western blot (bottom). (B) Summary of the data, which are normalized for c-Src abundance and plotted as percentage of control (pH 7.4); n = 6 for studies done with wild-type Pyk2 and n = 4 for studies done with the dominant-negative Pyk2. c-Src kinase activity was increased in 6 of 6 experiments in the presence of the wild-type Pyk2 and in 1 of 4 experiments in the presence of the dominant-negative Pyk2.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts